Kadimastem Valuation
| KDST Stock | ILA 485.00 35.00 6.73% |
At this time, the firm appears to be overvalued. Kadimastem secures a last-minute Real Value of 427.9 per share. The latest price of the firm is 485.0. Our model forecasts the value of Kadimastem from analyzing the firm fundamentals such as Return On Equity of -7.35, current valuation of 38.77 M, and Shares Owned By Insiders of 53.72 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Kadimastem's price fluctuation is very steady at this time. Calculation of the real value of Kadimastem is based on 3 months time horizon. Increasing Kadimastem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Kadimastem is useful when determining the fair value of the Kadimastem stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Kadimastem. Since Kadimastem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kadimastem Stock. However, Kadimastem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 485.0 | Real 427.9 | Hype 461.6 | Naive 460.23 |
The real value of Kadimastem Stock, also known as its intrinsic value, is the underlying worth of Kadimastem Company, which is reflected in its stock price. It is based on Kadimastem's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Kadimastem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kadimastem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kadimastem helps investors to forecast how Kadimastem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kadimastem more accurately as focusing exclusively on Kadimastem's fundamentals will not take into account other important factors: Kadimastem Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Kadimastem's current stock value. Our valuation model uses many indicators to compare Kadimastem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kadimastem competition to find correlations between indicators driving Kadimastem's intrinsic value. More Info.Kadimastem is currently regarded as number one stock in price to earning category among related companies. It is currently regarded as number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kadimastem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kadimastem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kadimastem's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kadimastem's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kadimastem and how it compares across the competition.
About Kadimastem Valuation
The stock valuation mechanism determines the current worth of Kadimastem on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Kadimastem. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kadimastem based exclusively on its fundamental and basic technical indicators. By analyzing Kadimastem's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Kadimastem's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kadimastem. We calculate exposure to Kadimastem's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kadimastem's related companies.Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. The company was founded in 2008 and is based in Ness Ziona, Israel. KADIMASTEM operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 28 people.
8 Steps to conduct Kadimastem's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Kadimastem's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kadimastem's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Kadimastem's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Kadimastem's revenue streams: Identify Kadimastem's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Kadimastem's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Kadimastem's growth potential: Evaluate Kadimastem's management, business model, and growth potential.
- Determine Kadimastem's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kadimastem's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kadimastem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Kadimastem Stock analysis
When running Kadimastem's price analysis, check to measure Kadimastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kadimastem is operating at the current time. Most of Kadimastem's value examination focuses on studying past and present price action to predict the probability of Kadimastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kadimastem's price. Additionally, you may evaluate how the addition of Kadimastem to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |